NCT03888300 Measurement of Viscoelastic Properties of Bronchopulmonary Secretions.
| NCT ID | NCT03888300 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Cliniques universitaires Saint-Luc- Université Catholique de Louvain |
| Condition | Obstructive Pulmonary Disease |
| Study Type | INTERVENTIONAL |
| Enrollment | 500 participants |
| Start Date | 2019-08-01 |
| Primary Completion | 2027-08-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 500 participants in total. It began in 2019-08-01 with a primary completion date of 2027-08-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The study is experimental and aims to (a) compare the viscoelastic properties of bronchial secretions obtained in patients suffering from obstructive respiratory disease, and (b) to compare the viscoelastic properties of bronchial secretions obtained in patients before and after application of a respiratory physiotherapy or exercise as usually prescribed. After agreement, the sputum of the participants will be collected according to the method used in clinical routine.Experiments (collection and analysis of sputum) will be conducted at the Saint-Luc University Clinic.
Eligibility Criteria
Inclusion Criteria: * obstructive pulmonary disease Exclusion Criteria: * none
Contact & Investigator
Gregory Reychler, PT, PhD
PRINCIPAL INVESTIGATOR
Cliniques universitaires Saint-Luc- Université Catholique de Louvain
Frequently Asked Questions
Who can join the NCT03888300 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Obstructive Pulmonary Disease. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT03888300 currently recruiting?
Yes, NCT03888300 is actively recruiting participants. Contact the research team at gregory.reychler@uclouvain.be for enrollment information.
Where is the NCT03888300 trial being conducted?
This trial is being conducted at Brussels, Belgium.
Who is sponsoring the NCT03888300 clinical trial?
NCT03888300 is sponsored by Cliniques universitaires Saint-Luc- Université Catholique de Louvain. The principal investigator is Gregory Reychler, PT, PhD at Cliniques universitaires Saint-Luc- Université Catholique de Louvain. The trial plans to enroll 500 participants.